Back to Woodline Partners LP Woodline Partners LP

VERAVERA

Showing 8 of 16 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in Vera Therapeutics, Inc.

Yes. Woodline Partners holds 1,001,037 shares of VERA (Vera Therapeutics), worth $43M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Woodline Partners has held VERA since Q3 2022, across 16 quarterly 13F filings. VERA is 0.1% of Woodline Partners' reported 13F portfolio.

Current Value

$43M

Current Shares

1M

Total Value Change

-$1.3M

Total Shares Change

+144

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
1M
0.0%
$43M0.1%$42.91
0
2026-Q1
Increased
1M
+0.1%
$40.3M0.2%$40.23
35
2025-Q4
Increased
1M
+35.6%
$50.7M0.2%$50.64
46
2025-Q3
Decreased
737,578
-71.7%
$21.4M0.1%$29.06
0
2025-Q2
Increased
2.6M
+160.6%
$61.5M0.3%$23.56
57
2025-Q1
Decreased
1M
-16.8%
$24M0.2%$24.02
0
2024-Q4
Increased
1.2M
+20.1%
$50.9M0.3%$42.29
42
2024-Q3
Increased
1M
+5.5%
$44.2M0.4%$44.20
37

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used